SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : CUBIST PHARMACEUTICALS (CBST)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: kenhott who wrote (248)4/19/2011 11:51:59 AM
From: kenhott   of 252
 
<reply> A bunch of OT for CBST, sorry. Only time for one quick reply. RE: AMRN, I personally took my money and ran. The issue for you to figure out (and then tell me pls) is will they get more than 3 years of FDA exclusivity and can they patent protect the product. Unless they get new drug ingredient label from the FDA, someone can file for generic soon after product launch. Over time, one big hint would be if a big pharma bites on the product. But AMRN was talking about self-marketing which to me maybe code word for trouble.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News